AhR and IDO1 in pathogenesis of Covid-19 and the “Systemic AhR Activation Syndrome:” a translational review and therapeutic perspectivesReview Published on 2020-01-012023-07-05 Journal: Restorative neurology and neuroscience [Category] SARS, [키워드] Aryl hydrocarbon receptor brain injury Corona virus COVID-19 Dexamethasone fibrosis Indoleamine 2,3-dioxygenase Inflammation multiple organ injury Physical exercise Respiratory failure SARS-CoV-2 systemic AhR activation syndrome (SAAS) Thromboembolism Vitamin D vitamin E. [DOI] 10.3233/RNN-201042 PMC 바로가기 [Article Type] Review